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ABSTRACT 
 
This paper presents a method of capturing viable 
circulating tumor cells (CTC) from human whole 
blood using constant-pressure-driven filtration through 
a specially designed parylene-C membrane “slot” filter.  
More than 90% viable cancer cells could be recovered 
from whole blood using the slot filter, with minimal 
non-cancer blood cells left on the filter.  The feasibility 
of the telomerase activity measurement of a single 
cancer cell taken from the filter after capture was 
proven.  The on-filter and off-filter cultures of the 
captured cancer cells were also demonstrated. 
 
INTRODUCTION 
 
Cancer metastasis is still the main cause of death for 
patients having solid-tumor cancers.  Circulating 
tumor cells (CTC) are tumor cells disseminated from 
the primary tumor into blood stream.  The presence of 
CTC in peripheral blood has important clinical 
significance for patients with various types of cancers. 
Study of CTC will also provide valuable insight into 
the mechanism of tumor metastasis. 
   
Most current CTC assays are used either for the 
enumeration of CTCs by immunostaining [1-7], or for 
specific molecular analysis by quantitative PCR 
(qPCR) [7,8].  For both applications, the main 
challenge is the extremely low concentration of CTC 
(e.g. ~1/mL).  Therefore, an enrichment step of rare 
CTCs from a large volume (e.g. in the milliliter range) 
of patient blood sample is crucial for successful CTC 
study.  So far, the reported CTC enrichment techniques 
include the density gradient centrifugation [7], 
immunomagnetic separation [7,8], microfluidic 
devices combined with immunoaffinity based 
selection [5,6] and size based filtration [1-4,7].  Size 
based filtration has been explored for solid-tumor 
cancers because the herein epithelial CTCs (15-30 µm 
in diameter) are generally larger and less deformable 
than normal blood cells.  Filtration devices adopting 
lateral flow usually suffer from long sample processing 
time and limited sample volume [4].  In contrast, 
membrane filters have the advantage of short operation 
time.  Single layer circular “pore” filters, including 
both the commercially available track-etched 
polycarbonate filters and microfabricated parylene 
filters, were reported and have been used in clinical 
trials [1,7].  However, these works mainly focused on 
fixed cells, which disallow further biological analysis 
requiring viable cells.  Moreover, the required fixation 
or sample dilution steps of some CTC enrichment 
approaches [1,7] can cause CTC damage or loss. 
 
Previously we reported two types of dual-layer 3D 
membrane filters [2,3] for the enrichment of viable 
cancer cells.  They showed good capture efficiency but 
low enrichment factor because too many blood cells 
were also trapped on the filters.  In this work, a 
specially designed single layer parylene “slot” filter is 
presented for viable CTC enrichment, capture and 
detection.  To prevent the damage of CTCs, a 
constant-pressure-driven fluid delivery system was 
designed for filtration.  More than 90% viable CTCs 
could be recovered from whole blood, with minimal 
non-cancer blood cells remaining on the filter.  Besides 
enumeration, the molecular analysis of telomerase 
activity on a single cancer cell removed from our filter 
using micropipette manipulation and qPCR was also 
demonstrated.  Moreover, the filtered cancer cells 
could be further cultured both on-filter and off-filter 
for future study. 
 
DESIGN AND FABRICATION 
 
Fig.1 shows the “slot” filter.  Parylene-C was used as 
the filter material because of its good mechanical 
properties, machinability, biocompatibility and optical 
transparency in the visible range.  The length of each 
slot was 40 µm, while the slot width was 6 µm, 
optimized by enumeration experiments.  The fill factor 
was 18%, which was much larger than previous “pore” 
filters [1].   
 
The filter fabrication process started from depositing a 
10 µm-thick parylene-C layer on prime silicon wafer 
(Fig.2). A metal layer, either Cr/Au or Al, was then 
deposited using a thermal evaporator, followed by 
lithography and wet-etching patterning.  Parylene-C 
was patterned by Reactive Ion Etching (RIE) using the 
metal as the mask.  Finally, the patterned parylene-C 
membrane was peeled off from the silicon substrate. 
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Figure 1: Membrane slot filter design 
 
 
Figure 2: Fabrication process 
 
The CTC filtration was carried out through a 
constant-pressure-driven fluid delivery system (Fig.3).  
The slot filter design and this fluid delivery system 
both contributed to the high viability capture.  First, 
compared to the circular pores, slots allow easier 
deformation of blood cells in the slot longitudinal 
direction, which facilitates easier passage of normal 
blood cells.  In addition to the slot design, the large fill 
factor also greatly reduces the flow resistance during 
filtration.  Secondly, in previous filtration approaches 
[1,2,7], samples were driven by hand-push or syringe 
pump.  Although a near-constant flow rate could be 
achieved, the pressure drop !"#$% across the filter 
increased when the filter was gradually clogged.  In 
contrast, the constant-pressure-driven fluid delivery 
system is &'()%*+%,))-%&%.+/0*&/*%"#%1234/5%64(*3&*4+/7  
The slot filter’s reduced flow resistance then allows a 
low and constant "#% to filter out CTCs, which 
minimizes the forces exerted on the cells, and hence 
results in high viability. 
 
 
Figure 3: Constant-pressure-driven system: (a) fluid 
delivery system, and (b) filter assembly. 
 
EXPERIMENTAL 
 
Human prostate cancer PC-3 cells were cultured in 
RPMI 1640 culture medium supplemented with 10% 
fetal bovine serum at 5% CO2
 
 and 37 ºC.  For filter 
device testing, harvested cells were first stained with 
Calcein-AM fluorescent dye (Invitrogen, Carlsbad, 
CA, USA), centrifuged and then resuspended in 
phosphate buffered saline (PBS) before testing.  
Known number of cancer cells were spiked into 1 mL 
human whole blood obtained from a healthy donor.  
After filtration, captured cancer cells were counted 
under epifluorescence microscope.  The viability of 
captured cancer cells was evaluated by on-filter 
staining with Propidium Iodide (PI) (Invitrogen).  
Enrichment was determined by staining white blood 
cells (WBCs) also captured on filter with Acridine 
Orange (AO) (Invitrogen) followed by WBC counting.  
To observe the morphology of captured cancer cells, 
cells on the filter went through the 
paraformaldehyde-glutaraldehyde fixation, multiple 
rinses, dehydration, air dry and sputter metal coating, 
and finally were viewed using a scanning electron 
microscope (SEM, JEOL JSM/6390LV). 
To perform molecular analysis on a single captured 
cell, several technologies were used together.  First, 
unlabeled PC-3 cells were spiked into 1mL blood and 
filtrated using a slot filter.  PE-conjugated anti-human 
CD49b antibody (BD biosciences, San Jose, CA, 
USA) was then used to selectively stain captured 
cancer cells on-filter.  Next, the filter was gently 
washed once in PBS.  Cancer cells were located under 
epifluorescence microscope and picked up 
individually from the filter through micropipette 
aspiration.  Glass micropipettes with tip diameter of 20 
µm were made by pulling glass capillaries using a P-87 
micropipette puller (Sutter Instrument Company, 
Novato, CA, USA).  The micropipette was mounted 
onto a XYZ stage.  Targeted single cancer cell was 
aspirated into the micropipette by capillary force.  The 
aspirated cell was lysed, and the telomerase assay was 
performed on the lysate by qPCR [9]. 
 
 To prove the feasibility of the culture of the captured 
cancer cells, 1mL whole blood spiked with unlabeled 
PC-3 cells was filtrated using slot filter, and the 
captured PC-3 cells were cultured either on-filter or 
off-filter.  For on-filter culture, the entire filter with 
captured cells was soaked inside RPMI complete 
culture medium.  For off-filter culture, captured cancer 
cells were first released from filter, and then cultured 
in a petri-dish with RPMI complete culture medium.  
In both cases, cells were maintained in an incubator at 
5% CO2
 
 and 37 ºC. 
RESULTS AND DISCUSSIONS 
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Three kinds of membrane slot filters with different slot 
widths, 5 µm, 6 µm and 7 µm, were tested for their 
capture efficiency, viability and enrichment (Fig.4).  
Capture efficiency was defined as the percentage of 
recovered on-filter cancer cells vs. the total spiked 
cancer cells.  Since the slot widths we studied were 
substantially smaller than PC-3 cancer cell size (~ 17 
µm in diameter), different slot widths did not cause 
significant variation of capture efficiency (Fig.4a).  
Cancer cell viability was the percentage of live cancer 
cells captured on filter, evaluated by both Calcein-AM 
and PI staining (Fig.5a&b).  Viable cancer cells with 
intact cell membrane were able to retain Calcein-AM, 
thus fluoresced green brightly.  Dead cancer cells with 
compromised cell membrane were stained by 
red-fluorescent nuclear dye PI, while the green 
fluorescence became faint due to Calcein-AM dye 
leakage.  A remarkable drop of viability was observed 
when the slot width increased to 7 µm (Fig.4a).  Under 
flow pressure and shear stress, captured cancer cells 
were forced to stretch and partially deform into the slot 
if the slot was too wide.  In this condition, the rupture 
of cell membrane and the internal damage of the cell 
were possible reasons for the drop of viability.  A 
noticeable reduction of capture efficiency can be 
predicted if the slot width further increases and cancer 
cells are able to deform through the slot.  Enrichment 
was defined as the ratio of WBCs remaining on filter to 
the total amount of WBCs.  A clear discrepancy 
appeared between 5 µm and 6 µm slot widths (Fig.4b).  
This difference was probably due to some large 
monocytes (12-20 µm) [1], which may have threshold 
passage width between 5 µm and 6 µm.  Based on 
above analysis, the filter with 6 µm slot width was the 
optimal design since it had over 90% capture 
efficiency and viability, with only 0.48% WBCs and 
minimal amount RBCs left on filter.  Filter 
performance under different drive pressures was also 
examined.  As drive pressure increased, both capture 
efficiency and viability decreased (Fig.4c).  Hence low 
drive pressure was critical for live cell capture.  
Experimentally, 0.13 psi was found as the optimal 
drive pressure for high viability and successful sample 
processing.  Filtration of 1mL sample under the 
optimal conditions took less than 5 minutes.  As so, the 
morphology of captured cancer cells remained 
unharmed as indicated by SEM (Fig.5c). 
 
Compared to normal cells, most cancer cells have 
higher telomerase activity, which directly indicates 
their malignant/metastatic potential [8,9].  Hence, the 
measurement of telomerase activity of CTCs is 
important for cancer metastasis study.  However, there 
are difficulties.  First, telomerase activity can only be 
measured from viable cells.  Secondly, although the 
telomerase activity of individual WBC is low, without 
an efficient enrichment, the telomerase activity from 
all the WBCs may still add high background noise to 
the telomerase activity of CTCs.  By picking up a 
single cancer cell using micropipette from the enriched 
viable cancer cells on the filter, we could isolate the 
single cancer cell and obtain its telomerase activity by 
sensitive qPCR.  Fig.6 shows the measured telomerase 
activity of both recovered cancer cells and control 
cells.  Different Ct values (threshold cycle) mean the 
telomerase activity varied among different cells.  
Higher telomerase activity (lower Ct) is associated 
with a more aggressive, metastatic cancer phenotype.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                    
 
 
 
 
 
 
Figure 4: Filter characterization: 
(a)(b) Capture efficiency, viability 
and enrichment with slot size at the 
same drive pressure of 0.13 psi; (c) 
Capture efficiency and viability 
with drive pressure with the same 
slot width of 6 µm. 
 
 
Figure 5: Cancer cells captured by 
filter from 1mL whole blood. (a)(b) 
Bright field and merged fluorescent 
pictures taken at same spot.  Live 
cells (green) stained with 
Calcein-AM; dead cells (red) 
stained with PI. (c) SEM picture of 
captured cancer cell. 
 
The culture of captured CTCs is highly desirable for 
further studies of the cancer cells.  However, most 
previously published methods had the problems of low 
viability, lack of biocompatible environment or 
incapability to release captured cells [1,2,5-7].  Here, 
the slot filter was demonstrated to have overcome 
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these problems, for both on-filter and off-filter culture.  
For on-filter culture, even without any surface 
pre-treatment, PC-3 cells were able to adhere and 
proliferate on the filter surface (Fig.7a).  For off-filter 
culture, trapped cells were first released and collected 
from the filter, by multiple rinses or reverse flow 
(passing PBS from backside), and then cultured in 
petri-dish (Fig.7b). 
 
 
 
Figure 6: Single cell telomerase measurement. (a) Use 
on-filter immunostaining to find the locations of 
cancer cells (red arrows: cancer cells; black arrows: 
blood cells); (b) Single cancer cell was picked up by 
micropipette aspiration; (c) Single cancer cell 
telomerase activity measured by qPCR. 
 
 
Figure 7: On-filter (a) and off-filter (b) cell culture of 
captured PC-3 cells from human blood after 3 days and 
6 days in RPMI complete medium.  Yellow arrows 
show examples of cancer cells spreading and dividing, 
and blue arrows show examples of remaining blood 
cells after filtration. 
 
CONCLUSION 
 
A parylene membrane slot filter and a 
constant-pressure-driven fluid delivery system were 
designed for the enrichment, capture and detection of 
viable CTCs from whole blood.  More than 90% viable 
cancer cells were captured, with minimal amount of 
non-cancer blood cells remaining on filter.  The 
feasibility of the telomerase activity measurement of a 
single cancer cell taken from the filter after filtration 
was proven.  The on-filter and off-filter cultures of the 
captured cancer cells were also demonstrated. 
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